Literature DB >> 12196591

Adenosine induces inositol 1,4,5-trisphosphate receptor-mediated mobilization of intracellular calcium stores in basal forebrain cholinergic neurons.

Radhika Basheer1, Elda Arrigoni, Hemant S Thatte, Robert W Greene, Indu S Ambudkar, Robert W McCarley.   

Abstract

In the cholinergic basal forebrain, we found previously that the extracellular adenosine concentration increase that accompanies sleep deprivation, acting via the A1 receptor, led to activation of the transcription factor nuclear factor-kappaB and to the upregulation of A1 adenosine receptor mRNA. We thus began to examine intracellular signaling mechanisms. We report here that adenosine, acting in a dose-dependent manner and predominantly via A1 receptors, stimulated IP3 receptor-regulated calcium release from intracellular stores. To the best of our knowledge, this calcium signaling pathway effect is a novel action of the G(i)-coupled A1 adenosine receptor in neurons. Moreover, this calcium mobilization was not seen at all in noncholinergic neurons but was present in a large proportion of cholinergic neurons. These data suggest a potential role for a calcium-signaling pathway in adenosine-induced long-term effects of sleep deprivation and a key role for cholinergic neurons in this process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196591      PMCID: PMC6758010     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  15 in total

1.  A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain.

Authors:  Mahesh M Thakkar; Stuart Winston; Robert W McCarley
Journal:  J Neurosci       Date:  2003-05-15       Impact factor: 6.167

2.  Adenosine A(1) receptor: Functional receptor-receptor interactions in the brain.

Authors:  Kathrin Sichardt; Karen Nieber
Journal:  Purinergic Signal       Date:  2007-09-05       Impact factor: 3.765

3.  The role of cholinergic basal forebrain neurons in adenosine-mediated homeostatic control of sleep: lessons from 192 IgG-saporin lesions.

Authors:  A V Kalinchuk; R W McCarley; D Stenberg; T Porkka-Heiskanen; R Basheer
Journal:  Neuroscience       Date:  2008-08-27       Impact factor: 3.590

Review 4.  The energy hypothesis of sleep revisited.

Authors:  Matthew T Scharf; Nirinjini Naidoo; John E Zimmerman; Allan I Pack
Journal:  Prog Neurobiol       Date:  2008-09-03       Impact factor: 11.685

Review 5.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

6.  Functional cooperation of metabotropic adenosine and glutamate receptors regulates postsynaptic plasticity in the cerebellum.

Authors:  Yuji Kamikubo; Takeshi Shimomura; Yosuke Fujita; Toshihide Tabata; Taku Kashiyama; Takashi Sakurai; Kenkichi Fukurotani; Masanobu Kano
Journal:  J Neurosci       Date:  2013-11-20       Impact factor: 6.167

Review 7.  Modulators of nucleoside metabolism in the therapy of brain diseases.

Authors:  Detlev Boison
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

8.  Amyloid beta-derived neuroplasticity in bone marrow-derived mesenchymal stem cells is mediated by NPY and 5-HT2B receptors via ERK1/2 signalling pathways.

Authors:  H K Jin; J S Bae; S Furuya; J E Carter
Journal:  Cell Prolif       Date:  2009-07-13       Impact factor: 6.831

Review 9.  Intracellular- and extracellular-derived Ca(2+) influence phospholipase A(2)-mediated fatty acid release from brain phospholipids.

Authors:  Angelo O Rosa; Stanley I Rapoport
Journal:  Biochim Biophys Acta       Date:  2009-03-25

10.  Adenosine-evoked hyperpolarization of retinal ganglion cells is mediated by G-protein-coupled inwardly rectifying K+ and small conductance Ca2+-activated K+ channel activation.

Authors:  Benjamin D Clark; Zeb L Kurth-Nelson; Eric A Newman
Journal:  J Neurosci       Date:  2009-09-09       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.